These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 8043280)

  • 1. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).
    Iwatsubo T; Odaka A; Suzuki N; Mizusawa H; Nukina N; Ihara Y
    Neuron; 1994 Jul; 13(1):45-53. PubMed ID: 8043280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease.
    Cairns NJ; Chadwick A; Lantos PL; Levy R; Rossor MN
    Neurosci Lett; 1993 Jan; 149(2):137-40. PubMed ID: 8474686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome.
    Iwatsubo T; Mann DM; Odaka A; Suzuki N; Ihara Y
    Ann Neurol; 1995 Mar; 37(3):294-9. PubMed ID: 7695229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations.
    Liepnieks JJ; Ghetti B; Farlow M; Roses AD; Benson MD
    Biochem Biophys Res Commun; 1993 Dec; 197(2):386-92. PubMed ID: 8267572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42).
    Akiyama H; Mori H; Sahara N; Kondo H; Ikeda K; Nishimura T; Oda T; McGeer PL
    Neurochem Res; 1997 Dec; 22(12):1499-506. PubMed ID: 9357016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a monoclonal antibody 369.2B specific for the carboxyl-terminus of the beta A4 peptide.
    König G; Graham P; Bushnell A; Webster S; Wunderlich D; Perlmutter LS
    Ann N Y Acad Sci; 1996 Jan; 777():344-55. PubMed ID: 8624111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain.
    Tamaoka A; Odaka A; Ishibashi Y; Usami M; Sahara N; Suzuki N; Nukina N; Mizusawa H; Shoji S; Kanazawa I
    J Biol Chem; 1994 Dec; 269(52):32721-4. PubMed ID: 7806491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques.
    Takahashi H; Kurashima C; Utsuyama M; Hirokawa K
    Acta Neuropathol; 1990; 80(3):260-5. PubMed ID: 1698004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques.
    Palmert MR; Podlisny MB; Witker DS; Oltersdorf T; Younkin LH; Selkoe DJ; Younkin SG
    Biochem Biophys Res Commun; 1988 Oct; 156(1):432-7. PubMed ID: 3140814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.